Literature DB >> 29793179

Nano strategies for berberine delivery, a natural alkaloid of Berberis.

Elaheh Mirhadi1, Mehdi Rezaee2, Bizhan Malaekeh-Nikouei3.   

Abstract

Berberine, as a phytochemical component of some medicinal Chinese herbs (most frequently Berberis vulgaris), is an isoquinoline alkaloid with many therapeutic effects including anti-viral, anti-microbial, anti-diarrhea, anti-inflammatory and anti-tumor effects. Berberine has some significant effects on type 2 diabetes through adenosine monophosphate-activated protein kinase activation, glycolysis stimulation, and mitochondrial function inhibition which subsequently improves both lipid and glucose metabolism. Some other effects of berberine on congestive heart failure, cardiac arrhythmia and hypertension have been reported. Beside the beneficial effects of berberine, some limitations including poor aqueous solubility, slight absorption, and low bioavailability have hindered its applications. To overcome these limitations, nanotechnology has been considered as main strategy. This review describes different types of nanocarriers (polymeric based, magnetic mesoporous silica based, lipid based, dendrimer based, graphene based, silver and gold nanoparticles) have been used for encapsulation of berberine.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aqueous solubility; Berberine; Bioavailability; Cancer therapy; Drug delivery; Nanocarriers

Mesh:

Substances:

Year:  2018        PMID: 29793179     DOI: 10.1016/j.biopha.2018.05.067

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  30 in total

1.  Antibacterial activity of a berberine nanoformulation.

Authors:  Hue Thi Nguyen; Tuyet Nhung Pham; Anh-Tuan Le; Nguyen Thanh Thuy; Tran Quang Huy; Thuy Thi Thu Nguyen
Journal:  Beilstein J Nanotechnol       Date:  2022-07-11       Impact factor: 3.272

2.  Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.

Authors:  Lin Wang; Bi-Qiang Zhou; Ying-Hong Li; Qian-Qian Jiang; Wei-Hong Cong; Ke-Ji Chen; Xiao-Min Wen; Zheng-Zhi Wu
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 3.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

4.  Gallic Acid and Gallic Acid Nanoparticle Modulate Insulin Secretion Pancreatic β-Islets against Silica Nanoparticle-Induced Oxidative Damage.

Authors:  Akram Ahangarpour; Hassan Sharifinasab; Heibatullah Kalantari; Mohammad Amin Dehghani; Nader Shakiba Maram; Fereshteh Golfakhrabadi
Journal:  Biol Trace Elem Res       Date:  2022-01-12       Impact factor: 4.081

5.  Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.

Authors:  Jianping Deng; Zicong Wu; Zhenling Zhao; Chaoxi Wu; Min Yuan; Zhengquan Su; Yifei Wang; Zhiping Wang
Journal:  Int J Nanomedicine       Date:  2020-06-03

Review 6.  Flaming the fight against cancer cells: the role of microRNA-93.

Authors:  Milad Ashrafizadeh; Masoud Najafi; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2020-06-29       Impact factor: 5.722

Review 7.  The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-04-18

Review 8.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

Review 9.  Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Authors:  Federica Fogacci; Davide Grassi; Manfredi Rizzo; Arrigo F G Cicero
Journal:  Phytother Res       Date:  2019-01-10       Impact factor: 5.878

Review 10.  Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.

Authors:  Miroslava Šudomová; Kateřina Berchová-Bímová; Stefania Marzocco; Alena Liskova; Peter Kubatka; Sherif T S Hassan
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.